Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
85.70    -1.70 (-1.95%)
Bid:
85.80
Ask:
86.60
Spread: 0.80 (0.932%)
Market Cap: £360.24m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

AGM Trading Statement

20 Nov 2025 07:00

RNS Number : 2634I
PZ CUSSONS PLC
20 November 2025
 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

20 November 2025

AGM TRADING STATEMENT

 

Ahead of its Annual General Meeting which takes place today, PZ Cussons issues the following update on current trading.

Like-for-like ('LFL') revenue growth for H1 FY26 is expected to be c.9%. This primarily reflects growth of over 25% in Africa, driven by both price and volume with the majority of brands gaining share during the first half of the year. Excluding Africa, LFL revenue growth is expected to be c.2%.

 

As a result of this performance to date, the Group is today increasing its guidance for FY26 adjusted operating profit to a range of £50 to £55 million, compared to a range of £48 to 53 million previously. Adjusted operating profit is expected to be weighted towards the first half of the year, with an increase in marketing spend in the second half.

 

The transaction to sell the Group's 50% stake in PZ Wilmar remains on track to complete by the end of the calendar year.

 

The Group expects to announce the outcome of the strategic review of its Africa business by the time it reports FY26 interim results on Wednesday 11 February.

 

For further information please contact:

Investors

Simon Whittington - IR and Corporate Development Director +44 (0) 77 1137 2928

 

Media

Headland PZCussons@headlandconsultancy.com +44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

 

Notes to Editors

 

About PZ Cussons

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK. We employ just under 2,500 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

Cautionary note regarding forward-looking statements

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand, along with risks associated with macroeconomic, political and social factors in the markets in which we operate. While we believe that the expectations reflected herein are reasonable based on the information we have as of the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the PZ Cussons Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The PZ Cussons Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward-looking statements contained within this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKLLFEFLLFBQ
Date   Source Headline
28th Sep 20165:30 pmRNSAGM Statement
28th Sep 20167:00 amRNSAGM Trading Statement
8th Sep 20165:30 pmRNSDirector/PDMR Shareholding
1st Sep 20161:11 pmRNSDirector/PDMR Shareholding
2nd Aug 20165:30 pmRNSDirector/PDMR Shareholding
27th Jul 20165:30 pmRNSDirector/PDMR Shareholding
26th Jul 201611:05 amRNSHolding(s) in Company
26th Jul 20167:00 amRNSFinal Results
20th Jul 20165:27 pmRNSHolding(s) in Company
11th Jul 201612:18 pmRNSHolding(s) in Company
6th Jul 201612:52 pmRNSHolding(s) in Company
4th Jul 20167:00 amRNSNotice of Adoption of FRS 101
30th Jun 20165:30 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTrading Statement
6th Jun 20167:00 amRNSDirectorate Change
3rd May 20167:00 amRNSChange to the Board of Directors
28th Apr 20165:30 pmRNSDirector/PDMR Shareholding
26th Apr 20167:00 amRNSChange to the Board of Directors
14th Apr 20167:00 amRNSTrading Statement
8th Apr 20167:00 amRNSDirector/PDMR Shareholding
23rd Mar 20165:30 pmRNSDirector/PDMR Shareholding
26th Jan 20167:00 amRNSInterim Results
31st Dec 201511:42 amRNSDirector/PDMR Shareholding
15th Dec 20158:32 amRNSDirector Declaration
10th Dec 20157:00 amRNSTrading Statement
30th Sep 20155:12 pmRNSDirector/PDMR Shareholding
22nd Sep 20154:48 pmRNSResult of AGM
22nd Sep 20157:00 amRNSAGM Trading Statement
11th Aug 20155:24 pmRNSHolding(s) in Company
6th Aug 20155:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20158:18 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSFinal Results
30th Jun 20155:30 pmRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSTrading Statement
9th Apr 20157:00 amRNSTrading Update
1st Apr 20157:00 amRNSBuy-out of Glanbia Plc's stake in Nutricima JV
30th Mar 20154:44 pmRNSDirector/PDMR Shareholding
13th Feb 201510:42 amRNSDirector/PDMR Shareholding
27th Jan 20157:00 amRNSHalf Yearly Report
5th Jan 20152:27 pmRNSDirector/PDMR Shareholding
10th Dec 20147:00 amRNSTrading Update
1st Oct 20145:30 pmRNSDirector/PDMR Shareholding
24th Sep 20143:20 pmRNSDirector/PDMR Shareholding
23rd Sep 20145:30 pmRNSResult of AGM
23rd Sep 20147:00 amRNSInterim Management Statement
15th Sep 20147:00 amRNSAppointment of joint Corporate Broker
29th Aug 20145:30 pmRNSDirector/PDMR Shareholding
27th Aug 20145:30 pmRNSDirector/PDMR Shareholding
1st Aug 20147:00 amRNSAcquisition of Australian food brand five:am
29th Jul 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.